ATW SPAC Management’s SeaStar Medical Holding Corp Warrant ICUCW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$6.64K Hold
245,200
0.01% 134
2025
Q2
$4.88K Hold
245,200
0.01% 108
2025
Q1
$8.61K Hold
245,200
0.01% 92
2024
Q4
$5.05K Hold
245,200
0.01% 105
2024
Q3
$10.6K Buy
+245,200
New +$16.9K 0.01% 105
2023
Q4
Sell
-245,200
Closed -$9.17K 191
2023
Q3
$3.46K Hold
245,200
﹤0.01% 170
2023
Q2
$8.95K Hold
245,200
0.01% 163
2023
Q1
$19.3K Hold
245,200
0.01% 126
2022
Q4
$22.1K Hold
245,200
0.01% 135
2022
Q3
$17K Hold
245,200
﹤0.01% 249
2022
Q2
$28K Hold
245,200
﹤0.01% 246
2022
Q1
$51 Hold
245,200
0.01% 235
2021
Q4
$2.46M Hold
245,200
0.38% 99
2021
Q3
$2.46M Sell
245,200
-4,800
-2% -$2.35K 0.46% 71
2021
Q2
$2.48M Buy
+250,000
New +$104K 0.64% 56

Other funds holding ICUCW

ATW SPAC Management's ICUCW Position: Q3 2025 in Review

ATW SPAC Management held its SeaStar Medical Holding Corp Warrant (ICUCW) position steady in Q3 2025 at 245,200 shares worth $6.64K. The position accounts for 0.01% of the portfolio, ranked #134.

ATW SPAC Management first reported a position in ICUCW in Q2 2021 and has held it in 15 quarters since. The position peaked at $2.48M in Q2 2021. 15 funds tracked by Wall St. Rank hold ICUCW as of Q3 2025.

  • ATW SPAC Management held 245,200 shares of SeaStar Medical Holding Corp Warrant worth $6.64K as of Q3 2025.
  • ATW SPAC Management left its SeaStar Medical Holding Corp Warrant share count unchanged in Q3 2025.
  • SeaStar Medical Holding Corp Warrant made up 0.01% of ATW SPAC Management's portfolio in Q3 2025, its #134 holding.
  • ATW SPAC Management first reported a position in SeaStar Medical Holding Corp Warrant in Q2 2021 and has held it in 15 quarters since.
  • ATW SPAC Management's SeaStar Medical Holding Corp Warrant position peaked at $2.48M in Q2 2021.
  • 15 funds tracked by Wall St. Rank held SeaStar Medical Holding Corp Warrant as of Q3 2025.

Based on ATW SPAC Management's 13F filing for Q3 2025, filed 12 Nov 2025.